VIP.

Quick Overview.

VIP (Vasoactive Intestinal Peptide) is a naturally occurring neuropeptide consisting of 28 amino acids. Originally discovered in the intestines (hence the name), it is now known to be widely distributed throughout the central and peripheral nervous systems. In the body, VIP acts as a potent vasodilator (widening blood vessels), a bronchodilator (opening airways), and a master regulator of the immune system.[1]

In the biohacking and functional medicine communities, VIP is primarily used as the final, critical step in the treatment of CIRS (Chronic Inflammatory Response Syndrome), a debilitating condition often triggered by toxic mold exposure (biotoxin illness) or chronic Lyme disease. In these patients, natural VIP levels plummet, leading to chronic fatigue, brain fog, and systemic inflammation. Intranasal VIP therapy restores these levels, downregulates the inflammatory response, and helps repair the brain.[2]

• Primary Use Case: CIRS (Mold Toxicity) recovery, systemic inflammation reduction, and neuro-regeneration.
• Mechanism: Binds to VPAC1 and VPAC2 receptors, shifting the immune system from a pro-inflammatory (Th1) state to an anti-inflammatory (Th2) state, while simultaneously downregulating Toll-like receptors (TLRs).[3]
• Who it is for: Patients diagnosed with CIRS who have already completed the prerequisite steps of biotoxin removal (e.g., using binders like Cholestyramine) and are looking to heal the remaining systemic damage.
• Who it is NOT for: Individuals currently living in a mold-toxic environment. Taking VIP while still exposed to the biotoxin is ineffective and can worsen symptoms.

The Protocol & Usage Guide.

confidence_tier: well-established

Because VIP is rapidly degraded in the bloodstream, it is almost exclusively administered via an intranasal spray for systemic and neurological effects.

Standard Dosing Schedule

Cycle Length & Discontinuation Protocol

• Cycle Length: VIP therapy for CIRS is a long-term commitment. Most clinical protocols (such as the Shoemaker Protocol) require patients to use VIP daily for 6 to 12 months to see full neurological and transcriptomic recovery.
• Timing: Doses should be spread evenly throughout the day (e.g., morning, noon, afternoon, evening).
• Discontinuation: Once blood markers (like TGF-beta 1 and C4a) normalize and symptoms resolve, patients can slowly taper off over several weeks.

Nutritional Support & Recommended Supplements.

confidence_tier: community

Safety, Interactions & Side Effect Management.

confidence_tier: well-established

Side Effect Profile

Contraindications

• Absolute: Elevated ERMI (Environmental Relative Moldiness Index) in the home. You cannot take VIP if you are still living or working in a water-damaged building. It will not work and may cause severe inflammatory flares.
• Absolute: Positive MARCoNS (Mold) nasal swab. You must clear any deep nasal staph/fungal infections before starting intranasal VIP.
• Relative: Individuals with naturally very low blood pressure, as VIP will lower it further.

Common Stacks & Combinations.

confidence_tier: well-established

Body Composition & Training Guide.

confidence_tier: well-established

• Not for Muscle Growth: VIP has no direct anabolic properties.
• Exercise Intolerance Recovery: One of the hallmark symptoms of CIRS is severe post-exertional malaise (PEM) due to mitochondrial dysfunction and capillary hypoperfusion. By restoring capillary blood flow (vasodilation) and reducing inflammation, VIP allows CIRS patients to gradually return to normal exercise routines without crashing.[4]

Storage, Handling & Accessibility.

confidence_tier: well-established

• Storage: VIP nasal sprays must be kept refrigerated at all times. The peptide is highly sensitive to heat and will degrade rapidly if left at room temperature.
• WADA Status: Not explicitly banned, but falls under general peptide restrictions.
• Accessibility: Available via prescription from functional medicine doctors and CIRS specialists (compounded by specialty pharmacies).

Bloodwork Monitoring Guide.

confidence_tier: well-established

In the context of CIRS, VIP therapy requires strict bloodwork monitoring to ensure it is working and safe to continue:

Comparison to Similar Compounds.

confidence_tier: well-established

Deep Dive (For Advanced Researchers).

confidence_tier: well-established

The Role of VIP in CIRS (Biotoxin Illness)

Chronic Inflammatory Response Syndrome (CIRS) occurs in genetically susceptible individuals (roughly 25% of the population with specific HLA-DR haplotypes) who cannot naturally clear biotoxins (like mold mycotoxins) from their bodies.

• The constant presence of these toxins causes the innate immune system to stay permanently "on," leading to a massive, chronic release of inflammatory cytokines.
• This chronic inflammation destroys the body's natural production of regulatory neuropeptides, specifically MSH (Melanocyte-Stimulating Hormone) and VIP.
• When VIP levels drop, capillary beds constrict (causing fatigue and muscle pain), pulmonary artery pressure rises (causing shortness of breath), and the brain actually begins to atrophy (shrink) due to neuroinflammation.[5]

Transcriptomic Healing and Brain Volumetrics

The most profound data regarding VIP comes from Dr. Ritchie Shoemaker's clinical trials on CIRS patients.

• Brain Atrophy Reversal: Using specialized NeuroQuant MRI software, researchers found that CIRS patients suffer from atrophy in specific brain regions (like the caudate nucleus) and swelling in others (like the forebrain parenchyma). A clinical trial demonstrated that intranasal VIP therapy not only resolved the cognitive symptoms but actually reversed the brain atrophy, restoring normal brain volumetrics.[6]
• Transcriptomics: A 2016 RNA-Seq study by Ryan and Shoemaker showed that CIRS patients have massive dysregulation in their gene expression (transcriptomics). Intranasal VIP therapy was shown to correct this dysregulation, effectively turning off the genes responsible for the chronic inflammatory response and restoring normal metabolic function.[7]

VIP in COVID-19 and Respiratory Failure

Because VIP is a potent bronchodilator and anti-inflammatory agent in the lungs, a synthetic version of VIP (Aviptadil) was heavily researched during the COVID-19 pandemic.

• A 60-day randomized controlled trial investigated IV Aviptadil in patients with critical COVID-19 respiratory failure. The study found that VIP upregulated surfactant production in the lungs, inhibited cytokine synthesis (preventing the "cytokine storm"), and improved survival rates in critically ill patients.[8]

Frequently Asked Questions (FAQ).

confidence_tier: community

Q: Can I just take VIP instead of doing the whole mold detox protocol? A: Absolutely not. This is the most common mistake people make. If you take VIP while still living in mold, or before you have cleared the toxins with binders, the VIP will act as a temporary band-aid at best, and at worst, it will trigger a massive inflammatory flare-up. It is the final step of healing, not the first.

Q: Why do I have to check my Lipase levels? A: In a small percentage of patients, VIP can irritate the pancreas. Monitoring Lipase (a pancreatic enzyme) ensures that you are not developing drug-induced pancreatitis.

Q: Will it help my asthma? A: Yes, VIP is a potent bronchodilator. In fact, early clinical trials in the 1980s showed that IV VIP caused significant bronchodilation in asthmatic volunteers. However, it is rarely prescribed solely for asthma today due to the availability of cheaper inhalers.

International Regulatory Status.

confidence_tier: well-established

Decision Tree.

confidence_tier: community

[Goal: Recover from CIRS / Mold Toxicity?]
  |
  +-- Are you still living or working in a water-damaged (moldy) building?
        |
        +-- (Yes) -> DO NOT USE VIP. You must remediate or move first.
        |
        +-- (No) -> Have you completed the binder protocol (e.g., Cholestyramine) and cleared MARCoNS?
              |
              +-- (No) -> Complete the prerequisite steps of the Shoemaker Protocol first.
              |
              +-- (Yes) -> Begin VIP Intranasal Spray (50mcg, 4x daily).
                           Monitor Lipase, TGF-beta 1, and C4a levels.

Schema.org Data.

{
  "@context": "https://schema.org",
  "@type": "MedicalEntity",
  "name": "Vasoactive Intestinal Peptide",
  "alternateName": ["VIP", "Aviptadil"],
  "description": "A potent anti-inflammatory and vasodilating neuropeptide. Used primarily as an intranasal spray in the final stages of the Shoemaker Protocol to reverse systemic inflammation and brain atrophy caused by Chronic Inflammatory Response Syndrome (CIRS).",
  "legalStatus": {
    "@type": "DrugLegalStatus",
    "description": "Prescription drug. Compounded off-label for CIRS."
  }
}

What we cited.